Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin.
about
Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary TractTreatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)A rare association of emphysematous pyelonephritis with unrecognized diabetes and polycystic kidneyType 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress.Lower blood glucose and variability are associated with earlier recovery from renal injury caused by episodic urinary tract infection in advanced type 2 diabetic chronic kidney disease.Risk factors associated with acute pyelonephritis in healthy womenAcute pyelonephritis in diabetes mellitus: Single center experience.Population-based epidemiologic analysis of acute pyelonephritis.Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States.Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and managementInteraction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritisEvidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristicsPredictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.Streptozocin-induced diabetic mouse model of urinary tract infection.Androgens Enhance Male Urinary Tract Infection Severity in a New ModelDrug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United StatesUrinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action.Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes.Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population-Based Case-Control Study in Taiwan.Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract.Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all childrenRenal scar formation and kidney function following antibiotic-treated murine pyelonephritis.Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study.Antimicrobial Selection in the Treatment of Pyelonephritis.Prevalence and risk factors for asymptomatic bacteriuria in women with Type 2 diabetes mellitus.The burden of common infections in children and adolescents with diabetes mellitus: A Pediatric Health Information System study.The Predictive Value of Glycated Hemoglobin and Albumin for the Clinical Course Following Hospitalization of Patients with Febrile Urinary Tract Infection
P2860
Q28829569-16B5E794-9DB9-451C-8A5E-69FE57C530F7Q33494958-06E3BB76-D25F-4D9F-89AA-286627111F5FQ33752147-6F3A6C95-BDEC-4CFF-A178-4C263849275FQ33954728-B8260195-5BFE-4367-A57C-A0FD8EA83287Q34258750-FE79D287-1BFE-42F6-967E-29B5DAFB749AQ34381168-71870D87-0AA5-4E95-A7FF-F9FA50F11275Q34574501-F35CFEF8-978F-4078-9940-2C4F7B92E9CCQ34643113-27766EF0-A38D-4CF5-9A33-C455DDD93DA1Q35096764-FF0A3999-7333-420B-9D68-61A32A1CC8B4Q35137036-39963355-2090-4FD3-8F40-22C1C95B5538Q35685988-61F4823C-01DF-439C-9ABC-4900A0FF0B81Q35855602-FCE24A54-5C67-4305-9DC9-1848F34EA7C3Q35896317-176EBB9D-BC06-4C06-AD60-E87BF7506112Q36589117-3334B27B-9C15-4645-9666-666BC783E416Q36845258-B0E26B71-5F0E-4A7D-B786-3CFFACB0624EQ36944667-B51C9792-1C00-4F31-8264-668AE8A669EBQ36951570-C14C8E08-514F-4018-BC78-B22D199C4384Q36974093-0454ADED-BB71-4192-8953-9D2693CB7238Q37324023-E2343FF6-A648-4F7D-BD04-20FB21FEAA61Q37781804-92CEE213-443C-4E51-8D44-3133F152841FQ38777020-7FFB451D-A25B-472A-925C-9B8DB4A62CDDQ39475552-E9D26565-865F-45EE-BFD1-0FC674AC3E5DQ39612821-2283ACF2-4E2F-48D2-A0CE-0C7DE5273212Q39690298-A4FEED5F-797A-4B91-AD54-201CACC01126Q40061790-1352CA92-DBE0-47CA-9436-A0EF7A988193Q40551854-9C3C59C9-2F68-40DF-BD5A-2F3118C27697Q45262813-3F2474F5-1F00-48E9-9343-8E045BD1715BQ46909191-887FE35B-5488-4BAE-A193-4C539DE84A6FQ47671574-F9D4F930-A11D-4F34-8EE7-48DF2608C516Q57124227-4B8199AE-CF74-4D98-B44A-7C589DCEFFC9
P2860
Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Hospitalization for acute pyel ...... gnancy, and aboriginal origin.
@en
type
label
Hospitalization for acute pyel ...... gnancy, and aboriginal origin.
@en
prefLabel
Hospitalization for acute pyel ...... gnancy, and aboriginal origin.
@en
P2093
P921
P356
P1476
Hospitalization for acute pyel ...... gnancy, and aboriginal origin.
@en
P2093
P304
P356
10.1093/CLINIDS/22.6.1051
P407
P577
1996-06-01T00:00:00Z